Jan B Groener Selected Research

Biomarkers (Surrogate Marker)

1/2022	Correction to: Neuron-specific biomarkers predict hypo- and hyperalgesia in individuals with diabetic peripheral neuropathy.
12/2021	Neuron-specific biomarkers predict hypo- and hyperalgesia in individuals with diabetic peripheral neuropathy.
1/2021	Diffusion Tensor Imaging of the Sciatic Nerve as a Surrogate Marker for Nerve Functionality of the Upper and Lower Limb in Patients With Diabetes and Prediabetes.
6/2017	Electrical Muscle Stimulation Induces an Increase of VEGFR2 on Circulating Hematopoietic Stem Cells in Patients With Diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jan B Groener Research Topics

Disease

11	Type 2 Diabetes Mellitus (MODY) 01/2021 - 07/2012
8	Diabetic Neuropathies (Diabetic Neuropathy) 12/2021 - 01/2016
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 12/2021
2	Hyperalgesia 01/2022 - 12/2021
2	Diabetes Complications 01/2020 - 04/2019
2	Pain (Aches) 01/2020 - 06/2017
2	Insulin Resistance 06/2016 - 02/2015
1	Acromegaly 01/2024
1	Chronic Disease (Chronic Diseases) 01/2024
1	Hyperglycemia 01/2024
1	Demyelinating Diseases (Demyelinating Disease) 12/2021
1	Prediabetic State (Prediabetes) 01/2021
1	Sciatic Neuropathy (Lesion of Sciatic Nerve) 01/2020
1	Diabetes Mellitus 04/2019
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Neuralgia (Stump Neuralgia) 12/2018
1	Albuminuria 01/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2016
1	Weight Loss (Weight Reduction) 02/2015
1	Inflammation (Inflammations) 02/2015
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2013
1	Hypothyroidism 01/2013
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2011

Drug/Important Bio-Agent (IBA)

6	NAD (NADH)IBA 01/2021 - 01/2018
4	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 02/2015
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2017
3	Coffee FDA Link 01/2018 - 02/2015
2	Metformin (Glucophage)FDA LinkGeneric 01/2024 - 02/2015
1	IncretinsIBA 01/2024
1	pasireotideIBA 01/2024
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2024
1	Hormones (Hormone)IBA 01/2024
1	Peptides (Polypeptides)IBA 01/2024
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2024
1	Growth Hormone (Somatotropin)IBA 01/2024
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2024
1	Proteins (Proteins, Gene)FDA Link 12/2021
1	Messenger RNA (mRNA)IBA 12/2021
1	Myelin P0 Protein (Myelin Protein Zero)IBA 12/2021
1	Troponin T (Troponin T1)IBA 01/2020
1	Oxygen (Dioxygen)IBA 04/2019
1	Pyruvaldehyde (Methylglyoxal)IBA 04/2019
1	CholesterolIBA 01/2019
1	diazonaphthalenedisulfonic acid (NDS)IBA 12/2018
1	AICA ribonucleotide (ZMP)IBA 06/2018
1	acadesineIBA 06/2018
1	Retinaldehyde (Retinal)IBA 01/2016
1	Insulin (Novolin)FDA Link 02/2015
1	Acarbose FDA LinkGeneric 02/2015
1	LipidsIBA 02/2015
1	IsotopesIBA 02/2015
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2013
1	Simvastatin (Zocor)FDA LinkGeneric 07/2012
1	oxidized low density lipoproteinIBA 07/2012
1	Ezetimibe (Zetia)FDA Link 07/2012
1	Tenofovir (Viread)FDA Link 09/2011
1	Emtricitabine (Emtriva)FDA Link 09/2011

Therapy/Procedure

2	Therapeutics 01/2024 - 07/2012
1	Thyroidectomy 01/2013